A big STEP for treatment of heart failure with preserved ejection fraction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A big STEP for treatment of heart failure with preserved ejection fraction

Published:2023-10 Issue:10 Volume:35 Page:1681-1687
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Verma Subodh,Borlaug Barry A.,Butler Javed,Davies Melanie J.,Kitzman Dalane W.,Petrie Mark C.,Shah Sanjiv J.,Dhingra Nitish K.,Kosiborod Mikhail N.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference15 articles.

1. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets;Borlaug;Cardiovasc. Res.,2023

2. Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials;Verma;EClinicalMedicine,2023

3. Once weekly semaglutide in heart failure with preserved ejection fraction and obesity;Kosiborod;N. Engl. J. Med.,2023

4. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC state-of-the-art review;Spertus;J. Am. Coll. Cardiol.,2020

5. Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved Trial;Butler;Circulation,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction;Journal of the American College of Cardiology;2024-08

2. Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction;Journal of the American College of Cardiology;2024-07

3. Semaglutide and NT-proBNP in Obesity-Related HFpEF;Journal of the American College of Cardiology;2024-07

4. Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial;European Journal of Heart Failure;2024-05-15

5. Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac Society;Polish Heart Journal;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3